期刊文献+

SARS S DNA疫苗不同免疫方案诱导细胞免疫应答的影响 被引量:3

Immune responses induced by SARS S DNA in different vaccinated strategies
原文传递
导出
摘要 目的观察SARS S DNA疫苗经不同的免疫途径及免疫次数,所诱导的免疫效果之间的差异。方法 C57BL/6小鼠经肌肉和皮下途径初次或加强免疫SARS S DNA疫苗,取其脾和肺淋巴细胞经S抗原多肽刺激以后,应用ELISA、ELISPOT和FACS等检测诱导细胞产生细胞因子情况。结果肌肉初次免疫后产生IFN-γ的量较低(均值脾:2.7 pg/ml;肺:68.9 pg/ml),加强免疫2次或3次后IFN-γ水平明显提高(脾:809.2~1398.7 pg/ml;肺:202.3~534.6 pg/ml),与初次免疫比较差异有统计学意义(脾P<0.001,肺P<0.05)。皮下二次免疫后IFN-γ产生量为54.3~106.1 pg/ml,但三次免疫后IFN-γ量显著提高均值达到729.1 pg/ml与对照组比较P<0.05。二次免疫后抗原特异性阳性细胞的频率肌肉免疫(188个/2×105细胞)高于皮下免疫(57个/2×105细胞),两者差异有统计学意义(P<0.05),而免疫3次后2种免疫途径可诱导数量相当的特异性阳性细胞(169~198个/2×105细胞,P>0.05)。S抗原特异性CD4+T细胞亚群以分泌IL-2为主,而抗原特异性CD8+T细胞分泌IFN-γ为主。结论经肌肉和皮下2种途径注射SARS S DNA疫苗免疫后,均可诱导小鼠产生特异性细胞免疫应答;加强免疫后诱导免疫应答明显强于初次免疫;肌肉免疫两次或皮下免疫三次后可达最佳免疫效果。 We aimed to evaluate the immune responses induced by SARS S DNA vaccine in different protocols.C57BL/6 mice were primed and boosted with SARS S DNA vaccine in intramuscular(i.m) or subcutaneous(s.c) ways.By day 7 after vaccination,single cells from spleen and lung were prepared and stimulated with pooled SARS S peptides.The production of cytokines was assayed by ELISA,ELISPOT and FACS.Significant higher level of IFN-γ(spleen: 809.2-1398.7 pg/ml;lung: 202.3-534.6 pg/ml) in culture supernatants were observed in i.m boosted mice than in those of primed ones(spleen: 2.7 pg/ml;lung: 68.9 pg/ml).The level of IFN-γ increased to 729.1 pg/ml in mouse s.c immunized for three times,which was higher than those in control groups(P〈0.05).After the second vaccination,i.m vaccinated mouse produced more frequencies of antigen specific cells(188 per 2×105 splenocytes) than s.c vaccinated ones(57 per 2×105 splenocytes,P〈0.05),however the frequency of s.c vaccinated ones was increased after the third vaccination(169-198 per 2×105 splenocytes,P〉0.05).We also found that S peptide specific CD4+ T cells mainly produced IL-2,though the most of IFN-γ was expressed by antigen specific CD8+ T cells.The above results indicated that specific cellular immune responses could be induced by both i.m and s.c vaccinations with SARS S DNA.And boost immunization enhances the cellular immune responses in vivo.The best immune responses are appeared after the second i.m vaccination and the third s.c vaccination.
出处 《免疫学杂志》 CAS CSCD 北大核心 2011年第1期13-18,共6页 Immunological Journal
基金 国家科技部863项目(2007AA02Z415)
关键词 严重急性呼吸综合征 疫苗 免疫应答 Severe acute respiratory syndrome Vaccine Immune response
  • 相关文献

参考文献22

  • 1Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome [J]. N Engl J Med, 2003, 348(20): 1967-1976.
  • 2Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome [J]. Lancet, 2003, 361(9366): 1319-1325.
  • 3See RH, Zakhartchouk AN, Petric M, et al. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus [J]. J Gen Virol, 2006, 87(Pt 3): 641-650.
  • 4Zhang CH, Lu JH, Wang YF, et al. Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivated vaccine prepared from F69 strain [J]. Vaccine, 2005, 23(24): 3196-3201.
  • 5Guo Y, Sun S, Wang K, et al. Elicitation of immunity in mice after immunization with the S2 subunit of the severe acute respiratory syndrome coronavirus [J]. DNA Cell Biol, 2005, 24(8): 510-515.
  • 6Yuen KY, Woo PC, Lau SK. An oral mucosal DNA vaccine for SARS coronavirus infections [J]. Hong Kong Med J, 2009, 15 (Suppl)2: 41-42.
  • 7Lu B, Tao L, Wang T, et al. Humoral and cellular immune responses induced by 3a DNA vaccines against severe acute respiratory syndrome (SARS) or SARS-like coronavirus in mice [J]. Clin Vaccine Immunol, 2009, 16(1): 73-77.
  • 8Martin JE, Louder MK, Holman LA, et al. A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial [J]. Vaccine, 2008, 26(50): 6338-6343.
  • 9Zhao K, Yang B, Xu Y, et al. CD8^+ T cell response in HLA- A*0201 transgenic mice is elicited by epitopes from SARS-CoV S p otem [J]. Vaccrue, 2010, 28(41):6666-6674.
  • 10Huang J, Cao Y, Du J, et al. Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4^+ and CD8^+ T cells promote cellular immune responses [J]. Vaccine, 2007, 25(39/40): 6981-6991.

二级参考文献8

共引文献2

同被引文献10

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部